BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 29675925)

  • 1. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
    Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
    Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
    Wang Z; Zhang J; Li M; Kong L; Yu J
    Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
    Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H
    Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Kawasaki Y; Okumura H; Uchikado Y; Kita Y; Sasaki K; Owaki T; Ishigami S; Natsugoe S
    Ann Surg Oncol; 2014 Jul; 21(7):2347-52. PubMed ID: 24599410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy.
    Zhao Z; Zhang Y; Wang X; Geng X; Zhu L; Li M
    Cancer Med; 2020 Aug; 9(16):5881-5888. PubMed ID: 32627960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Factor Erythroid 2-Related Factor 2/Kelch-Like ECH-Associated Protein 1 as a Predictor of Prognosis and Radiotherapy Resistance in Patients With Locally Advanced Rectal Cancer: A Prospective Analysis.
    Park JM; Kim S; Bae SU; Byun SJ; Seo I; Lee HW
    J Korean Med Sci; 2023 Jul; 38(26):e200. PubMed ID: 37401495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.
    Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC
    J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
    Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
    Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Akdemir B; Nakajima Y; Inazawa J; Inoue J
    Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Elimination of NRF2-Activated Cells by Competition With Neighboring Cells in the Esophageal Epithelium.
    Hirose W; Horiuchi M; Li D; Motoike IN; Zhang L; Nishi H; Taniyama Y; Kamei T; Suzuki M; Kinoshita K; Katsuoka F; Taguchi K; Yamamoto M
    Cell Mol Gastroenterol Hepatol; 2023; 15(1):153-178. PubMed ID: 36115578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Remission and Tumor-Infiltrating Lymphocytes During Chemoradiation Therapy: Predictive and Prognostic Markers in Locally Advanced Esophageal Squamous Cell Carcinoma.
    Qian D; Wang Y; Zhao G; Cao F; Er P; Chen X; Cheng J; Zhang W; Li X; Zhang B; Guan Y; Zhou D; Wang J; Jiang H; Yu Z; Yuan Z; Wang P; Pang Q
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):319-328. PubMed ID: 31228553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
    Tong YS; Zhou XL; Wang XW; Wu QQ; Yang TX; Lv J; Yang JS; Zhu B; Cao XF
    J Transl Med; 2014 Aug; 12():233. PubMed ID: 25169763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic Keap1 Expression Is Associated With Poor Prognosis in Endometrial Cancer.
    Ahtikoski AM; Kangas J; Salonen R; Puistola U; Karihtala P
    Anticancer Res; 2019 Feb; 39(2):585-590. PubMed ID: 30711933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and correlation of NRF2, KEAP1, NQO-1 and HO-1 in advanced squamous cell carcinoma of the larynx and their association with clinicopathologic features.
    Li C; Wu H; Wang S; Zhu J
    Mol Med Rep; 2016 Dec; 14(6):5171-5179. PubMed ID: 27840932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.
    Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC
    J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors.
    Yamamoto S; Inoue J; Kawano T; Kozaki K; Omura K; Inazawa J
    Mol Cancer Res; 2014 Jan; 12(1):58-68. PubMed ID: 24307696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
    Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
    Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.